Humana Raises 2026 Profit Forecast as Medical Costs Beat Expectations

What did Humana change in its 2026 earnings forecast?

Humana increased its full year adjusted earnings floor by $0.50 to $9.50 per share and raised its GAAP earnings guidance to at least $15.09 per share from $6.52, with the larger GAAP revision reflecting significant valuation and other accounting adjustments.

Orbitrum Investor Impact

Why did lower medical costs improve Humana's profit outlook?

Humana's third quarter insurance benefit ratio was 93.7%, below the 94.39% analyst estimate, meaning medical claims consumed less premium revenue than expected and supported insurance profitability.

Why does Humana still expect lower adjusted earnings than in 2025?

Despite the upgraded forecast, Humana's 2026 adjusted earnings floor remains substantially below the $17.14 per share reported for 2025 because reduced Medicare Advantage Star Ratings bonuses continue to pressure profitability.

What could the upgraded forecast mean for Humana stock?

The improvement supports the earnings outlook for NYSE listed Humana shares (HUM), but the third quarter adjusted loss of $0.70 per share and the expected annual profit decline show that the company's earnings recovery remains incomplete.

What should Humana investors watch next?

Investors should monitor fourth quarter medical costs and Humana's execution of its 2027 Medicare Advantage pricing strategy, which management expects to support its goal of achieving a sustainable pretax margin of at least 3% in 2028.